Solution Biologics bottling CanSino vaccine at Bukit Jalil. - Filepic
KUALA LUMPUR: Solution Group Bhd
(SGB) is confident that the China-based single-dose Convidecia vaccine will be an effective booster shot against the spread of Covid-19 variants.
SGB’s wholly-owned subsidiary, Solution Biologics Sdn Bhd (Solbio), is the Asean manufacturing partner for CanSino’s Convidecia vaccine.
In a statement yesterday, SGB said data from a recent Chinese clinical study showed that a booster shot with the Convidecia vaccine, following a two-dose inactivated vaccine, is effective to produce an immune response to the Covid-19 virus.
“The study by the Jiangsu Centre of Disease Control revealed that the Convidecia booster shot demonstrated an increase of at least 78-fold in average neutralising antibody levels, in comparison with a booster shot with the same inactivated vaccine showing a 15.2-fold increase in antibody levels,” it said.
